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The purpose of this study is to determine whether the
angiotensin-converting enzyme (ACE) gene polymorph-
ism is associated with retinal arteriolar narrowing, a
subclinical marker of chronic hypertension. The Funa-
gata Study examined a population-based sample of
Japanese aged 35þ years; 368 participants had both
retinal vessel diameter measurements and ACE inser-
tion/deletion (ACE I/D) polymorphism analyses per-
formed. Assessment of retinal vessel diameter and
retinal vessel wall signs followed the protocols used in
the Blue Mountains Eye Study. ACE gene polymorph-
isms D/D, I/D and I/I were present in 34 (9.2%), 170
(46.2%) and 164 (44.5%) participants, respectively,
distributed in Hardy–Weinberg equilibrium. After multi-
variable adjustment, retinal arteriolar diameter was
significantly narrower in subjects with the D/D genotype
compared to subjects with I/D and I/I genotypes (mean
difference  6.49lm, 95% confidence interval (CI):
 12.86lm,  0.11lm). Our study suggests that the
ACE I/D polymorphism may be associated with sub-
clinical structural arteriolar changes related to chronic
hypertension.
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Introduction
Retinal arteriolar narrowing is a structural micro-
vascular sign associated with chronic hypertension
1
that predicts the risk of stroke
2 and coronary heart
disease.
3 Recent studies suggest that a substantial
proportion of the variation in retinal arteriolar
diameter might be genetically determined, indepen-
dent of concomitant risk factors.
4 However, no
definite candidate genes associated with retinal
arteriolar diameter have yet been consistently
identified.
Angiotensin-converting enzyme (ACE) is a key
component of the renin–angiotensin system and can
promote vasoconstriction, inflammation, thrombo-
sis and vascular remodeling. It was reported that
there was a high level of ACE expression in the
regions of atherosclerotic lesions in human vascu-
lature.
5 Retinal arteriolar narrowing, which reflects
intimal thickening, medial hyperplasia and hyalini-
zation and sclerosis of retinal arterioles has also
been associated with atherosclerosis.
Polymorphisms in the ACE gene, absence (dele-
tion, D allele) rather than presence (insertion,
I allele) of the 287-bp Alu insert in intron 16, has
been found associated with hypertension,
6 carotid
wall thickening
7 and coronary heart disease.
8 The D
allele of this polymorphism was also reportedly
associated with two-fold higher circulating levels of
ACE.
9
It was reported that ACE gene and renin mRNA
(messenger ribonucleic acid) expressed in the
retinal pigment epithelium, the choroid and neural
retina of rats.
10 This suggested that the local renin–
angiotensin system (RAS) is likely involved in the
regulation of the retinal vasculature. Furthermore,
one study suggested that patients with hypertensive
retinopathy were more likely to have the D/D
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However, there were no studies that had examined
the association of the ACE gene with quantitatively
measured retinal vessel diameter.
The purpose of this study is to determine the
independent association of ACE I/D polymorphisms
and retinal arteriolar narrowing, and whether this
association is independent of measured blood
pressure and other cardiovascular risk factors.
Materials and methods
Study population
The Funagata study is a population-based epide-
miologic study examining diabetes and other vas-
cular disease in adult Japanese persons aged 35
years or older. Details of study participants and
research methodology were described elsewhere.
12
In this study, systemic and ophthalmologic data
were obtained between June 2000 and June 2002. Of
3676 eligible residents in Funagata community, 743
(20.2%) agreed to participate in the genetic part of
the study. Participants included in this current
study had a lower frequency of pre-diabetes and
diabetes than those excluded (22.8 vs 30.7%;
P¼0.003). There were no significant differences
between included and excluded participants in
other demographic characteristics, such as age,
gender, smoking, body mass index and systolic
and diastolic blood pressure. Of the 743, 651
(87.6%) had fundus photographs with sufficient
quality for assessment of retinal microvascular
structural signs. Only 368 (49.5%) participants with
retina–optic disc photographs had adequately cap-
tured a sufficient number of retinal vessels within a
zone 0.5 disc diameter away from the optic disc
margin, to grade retinal vessel diameter using a
standardized computer-assisted method.
13 Written
consent was obtained from all study participants,
the study was conducted according to the recom-
mendation of the Declaration of Helsinki and was
approved by the Ethics Committee of the Yamagata
University Faculty of Medicine, Yamagata, Japan.
Assessment of retinal microvascular changes
Fundus photographs were taken using non-stereo-
scopic 451 non-mydriatic fundus camera (CR5-
NM45, Canon Inc., Tokyo, Japan; and TRC, Topcon
Inc., Tokyo, Japan); a single field centered between
the macula and optic disc was taken. Fundus
photographs were graded for retinal microvascular
signs at the Centre for Vision Research, University of
Sydney, Australia. Grading was performed by a
trained grader following a standard protocol; details
of image preparation and grading protocols have
been described previously.
13,14 In brief, retinal
photographs on 35-mm film were converted to
digital images using a high-resolution scanner
(LS2000; Nikon, Tokyo, Japan). Digital images were
centered on the optic disc, and all vessels passing
through the entire zone between 0.5 and 1 disc
diameter away from the disc margin were measured
using image analysis software (Retinal Analysis,
Department of Ophthalmology Visual Science, Uni-
versity of Wisconsin, WI, USA). A trained grader
identified each vessel either as an arteriole or
venule. The computer program measured and
calculated the average width from five equidistant
measures of each vessel. The average diameter of
retinal vessels was calculated using the Parr–
Hubbard formula, and summarized as the central
retinal artery equivalent (CRAE) and the central
retinal vein equivalent (CRVE), representing the
average arteriolar and venular diameter, respec-
tively.
15,16
Retinal arteriolar wall signs (focal arteriolar
narrowing, arterio-venous nicking and enhanced
arteriolar wall reflex) and retinopathy signs (micro-
aneurysms, retinal hemorrhages and exudates) were
also graded using a light box method following the
standard photographs selected by a retinal specialist
(PM) from the standard photographic sets developed
for the Modified Airlie House Classification of
Diabetic Retinopathy
17 and the Wisconsin Age-
Related Maculopathy Grading System.
18 All grading
was performed by a trained grader and adjudicated
by a senior researcher (JJW) and a retinal specialist
(PM).
12
Assessment of systemic characteristics
Blood pressure was measured after rest for 5min,
and using a mercury sphygmomanometer. Hyperten-
sion status was defined for systolic blood pressure
X140mmHg or diastolic blood pressure
X90mmHg, or if persons had a previous diagnosis
of hypertension and were using anti-hypertensive
medications. Diabetes or pre-diabetes was defined
as having fasting plasma glucose X110mgdl
 1 or 2h
post-load glucose X140mgdl
 1. Smoking status was
assessed during an interview. Body mass index was
calculated as weight (kg) divided by the square of
height (m).
Assessment of insertion/deletion polymorphism
of 287bp Alu insert in intron 16 of ACE gene
Genomic DNA was isolated from peripheral blood
leukocytes by proteinase K and the phenol/chloro-
form extraction procedure. Insertion (I) or deletion
(D) of the 287-bp Alu insert in intron 16 of the ACE
gene was determined by polymerase chain reaction
fragment length polymorphism analysis.
19 The fre-
quency of the D and I allele were 32.3% (n¼238)
and 67.6% (n¼498), respectively. The frequency of
D/D, I/D and I/I were 9.2% (n¼34), 46.2% (n¼170)
and 44.6% (n¼164), respectively. The genotypes
frequency was found to be in Hardy–Weinberg
equilibrium.
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Data analysis was performed by statistical analysis
software (Stata 10, StataCorp, TX, USA and SPSS
14.0, SPSS Inc., Chicago, USA). Demographic
characteristics among three genotype groups were
compared using analysis of variance. To examine
whether the ACE I/D polymorphism was associated
with retinal vessel diameter, linear regression
analysis was used, with retinal vessel diameter as the
dependent variable, adjusting for cardiovascular risk
factors selected based on our previous analysis.
12
Associations between the ACE I/D polymorphism
and presence of retinal arteriolar wall signs/retino-
pathy were examined using logistic regression
models while adjusting for cardiovascular risk
factors. Crude, age–gender adjusted and multivari-
able (age, gender, systolic blood pressure, smoking
status and body mass index) adjusted estimates for
the associations are presented. We used models
following additive models (I/I vs I/D vs D/D),
dominant models (I/I vs I/D or D/D) or recessive
models (I/I or I/D vs D/D). Models for CRAE
additionally adjusted for CRVE and vice versa.
20
We also analyzed if the interaction between ACE I/D
polymorphism (D/D vs I/D or I/I) and hypertension
status (hypertension vs normotension) affected
retinal vessel diameters. We further examined if
the ACE I/D polymorphism was associated with
systolic and diastolic pressure; linear regression was
used to estimate the mean differences in systolic and
diastolic blood pressure by ACE I/D polymorphism,
adjusting for other cardiovascular risk factors.
Results
Demographic characteristics by ACE I/D polymorph-
ism are presented in Table 1. There were no
significant differences in demographic characteris-
tics among ACE I/D polymorphism groups.
Difference in systolic and diastolic blood pressure
by ACE I/D polymorphisms
Mean systolic and diastolic blood pressure was
highest in subjects with I/I polymorphism, although
these were not statistically significant (Table 1).
Table 2 shows relationships between ACE I/D
polymorphism and blood pressure status. Mean
diastolic pressure was significantly lower in sub-
jects with D allele (D/D or I/D) compared with that
in subjects with I/I ( 2.50mmHg 95% CI:
 4.78mmHg,  0.23mmHg) after adjusting for age,
gender, body mass index and smoking status.
However, there was no significant difference in
systolic blood pressure (1.43mmHg, 95% CI:
 4.82mmHg, 7.68mmHg) and no significant asso-
ciation between the presence of hypertension and
the ACE I/D polymorphisms (odds ratio for D/D
compared with I/I: 1.02, 95% CI: 0.38–73).
Difference in retinal vessel diameters by ACE I/D
polymorphisms
Table 3 shows relationships between ACE I/D
polymorphism and CRAE. Mean CRAE (± s.d.) for
subjects with D/D, I/D and I/I polymorphism was
173.77±19.73mm, 179.46±20.54mm and 179.50±
20.39mm, respectively. After adjusting for CRVE,
CRAE was significantly smaller in subjects with D/D
compared with that in subjects with I/I by  6.69mm
(95% confidence interval (CI) for the b coefficient:
 12.88mm,  0.51mm). This remained significant
after age–gender ( 6.60mm, 95% CI:  12.78mm,
 0.42mm) and multivariable adjustment ( 6.86mm,
95%CI:  13.58mm,  0.13mm). Similar findings are
obtained when comparing subjects with D/D with
those with the I allele (I/D and I/I) after adjusting for
CRVE, age–gender or multiple variables (Table 3).
There were no significant differences in mean CRAE
between subjects with I/I and I/D polymorphism, or
between subjects with I/I and those with D allele
(I/D and D/D polymorphisms) (Table 3).
Table 3 shows CRVE by ACE I/D polymorphism.
Mean CRVE for the subjects with D/D, I/D and I/I
polymorphisms was 217.37±20.07mm, 216.12±
20.37mm and 215.61±21.52mm, respectively
Mean CRVE was non-significantly larger in subjects
with D/D compared with that in subjects with I/I
or I/D.
After adjusting for CRVE, subjects with hyperten-
sion had significantly smaller CRAE than those who
were normotensive by  3.63mm (95% CI;  7.11mm,
Table 1 Demographic characteristics by polymorphism of insertion (I) or deletion (D) of the 287 bp Alu insert in intron 16 of the
angiotensin-converting enzyme (ACE) gene, The Funagata Study, Japan, 2000–02
D/D polymorphism I/D polymorphism I/I polymorphism P-value
N¼34 N¼170 N¼164
Male gender (%) 17 (50) 67 (39.4) 67 (40.9) 0.518
Hypertension (%) 13 (38.2) 70 (41.2) 64 (39.0) 0.915
Pre-diabetes or diabetes (%) 6 (17.6) 39 (22.9) 39 (23.7) 0.739
Current smoker (%) 3 (8.8) 32 (18.8) 25 (15.2) 0.313
Mean (s.d.)
Age, years 58.9 (11.6) 60.1 (11.6) 60.5 (10.9) 0.776
Body mass index, kgm
 2 24.5 (3.2) 23.4 (3.1) 24.0 (3.5) 0.159
Systolic blood pressure, mmHg 127.8 (17.0) 125.9 (15.5) 128.0 (15.5) 0.447
Diastolic blood pressure, mmHg 75.3 (8.8) 75.1 (9.7) 77.2 (10.6) 0.169
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polymorphism and hypertension was not signifi-
cantly associated with CRAE after adjusting for
CRVE ( 8.71mm, 95% CI;  20.76mm, 3.34mm).
Association of retinal arteriolar wall signs/retinopathy
and ACE I/D polymorphism
There was no significant association between focal
retinal arteriolar wall signs (focal arteriolar narrow-
ing, arterio-venous nicking and enhanced arteriolar
wall reflex) or retinopathy and the ACE I/D poly-
morphisms (data not shown).
Discussion
In this population-based study of adult Japanese, we
reported associations between the ACE I/D poly-
morphism and retinal arteriolar narrowing, a sub-
clinical structural microvascular sign associated
with chronic hypertension. We found that retinal
arteriolar diameter was smaller in subjects with D/D
than those with the I allele after adjusting for
systolic blood pressure and other cardiovascular
risk factors. We also found that diastolic blood
pressure was significantly lower in subjects with D
allele polymorphism compared with I/I polymorph-
ism, but there was no difference in systolic blood
pressure and no association for the presence of
hypertension by the ACE I/D polymorphism.
Retinal arteriolar narrowing is a structural micro-
vascular sign associated with chronic hypertension;
1
it has been shown to predict the incidence of stroke
2
and coronary heart disease.
3 On the other hand,
other studies suggested that retinal arteriolar nar-
rowing might be antecedent of the hypertension,
and involved in the pathogenesis of hypertension
itself. If retinal arteriolar narrowing is associated
with genetic disposition, such as ACE I/D poly-
morphism, which we have examined assessing the
retinal vessel diameters will enable us to stratify
those who are vulnerable to developing hyperten-
sion or further cardiovascular diseases. The Beaver
Dam Eye Study showed that genetic factors affected
retinal vessel diameters in a genome-wide linkage
analysis.
4 Within or near the linkage regions with
retinal vessel diameter, there were genes associated
with endothelial function, vasculogenesis, hyper-
tension and coronary heart disease.
4 However, to
date, exact genes associated with retinal vessel
diameter have not been identified.
The RAS and endothelial cells are intimately
involved in atherosclerosis.
5 It is known that local
RAS exists in the eye,
10 and retinal vascular
endothelial cells can express angiotensin type 1
receptors.
21 Previous experimental reports in studies
of streptozocin-induced diabetic rats revealed that
RAS inhibition ameliorates endothelial dysfunc-
tion.
22 Retinal vessel diameter has also been linked
with endothelial dysfunction, with studies showing
association of retinal arteriolar narrowing with von
Willebrand factor and factor VIII, which are sys-
temic markers of endothelial dysfunction.
23 There-
fore, our findings that D/D polymorphism is
associated with narrower retinal arteriolar diameters
Table 2 Difference in systolic and diastolic blood pressure (mmHg) and odds ratio in hypertension , by angiotensin-converting enzyme
insertion/deletion polymorphisms, the Funagata Study, Japan, 2000–02
N Mean blood
pressure (mmHg)
Crude difference
(95%CI) (mmHg)
Age–gender-adjusted
(95%CI) (mmHg)
Multivariable adjusted
(95%CI) (mmHg)
a
Systolic blood pressure
D)I/I polymorphism 164 128.0±15.5 (reference) (reference) (reference)
I/D or D/D 204 126.2±15.8  2.67 ( 6.27, 0.93)  2.32 ( 5.70, 1.07)  1.76 ( 5.00, 1.48)
R)I/D or I/I polymorphism 334 126.9±15.5 (reference) (reference) (reference)
D/D 34 127.8±17.0 2.06 ( 4.09, 8.21) 3.06 ( 2.73, 8.85) 2.16 ( 3.46, 7.79)
Diastolic blood pressure
D)I/I polymorphism 164 77.2±10.6 (reference) (reference) (reference)
I/D or D/D 204 75.2±9.6  2.98 ( 5.36,  0.59)*  2.88 ( 5.24,  0.51)*  2.50 ( 4.78,  0.23)*
R)I/D or I/I polymorphism 334 76.1±10.2 (reference) (reference) (reference)
D/D 34 75.3±8.8  0.06 ( 4.17, 4.04) 0.16 ( 3.93, 4.24)  0.45 ( 4.43, 3.53)
N Prevalence (%) Crude (95%CI) Age–gender-adjusted
(95% CI)
Multivariable adjusted
(95% CI)
a
Hypertension
A)I/I polymorphism 164 64 (39.0) (reference) (reference) (reference)
I/D 170 70 (41.2) 1.09 (0.71, 1.70) 1.07 (0.48, 2.42) 0.91 (0.37, 2.58)
D/D 34 13 (38.2) 0.97 (0.45, 2.07) 1.12 (0.70, 1.79) 0.98 (0.52, 1.60)
D)I/I polymorphism 164 64 (39.0) (reference) (reference) (reference)
I/D or D/D 204 83 (40.7) 1.07 (0.70, 1.63) 1.11 (0.71, 1.74) 0.92 (0.54, 1.58)
R)I/D or I/I polymorphism 334 134 (40.1) (reference) (reference) (reference)
D/D 34 13 (38.2) 0.92 (0.45, 1.91) 1.01 (0.46, 2.20) 1.03 (0.41, 2.59)
Abbreviations: D, deletion polymorphism; I, insertion polymorphism.
aAdjusted for age, gender, systolic blood pressure, body mass index and smoking status.
*Po0.05.
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retinal vasculature.
Our study shows both ACE I/D polymorphism and
hypertension-influenced retinal arteriolar dia-
meters. However, we could not confirm whether an
interaction between the D/D polymorphism and the
presence of hypertension affecting retinal arteriolar
diameters exists. Because there were only 13
subjects (38.2%) with D/D polymorphism who have
hypertension in this study, a statistical power may
be weak to prove this association.
In this older Japanese population, presence of the
I allele is associated with essential hypertension.
24
In contrast, the D allele of the ACE I/D polymorph-
ism has been associated with atherosclerosis.
7
Retinal arteriolar narrowing, which reflects intimal
thickening, medial hyperplasia and hyalinization
and sclerosis of retinal arterioles has also been
associated with atherosclerosis.
25 Our findings that
the ACE I/D polymorphism is linked to retinal
arteriolar narrowing may also be explained by its
association with atherosclerotic processes.
Limitations and potential biases of this study
should be mentioned. First, only 20.2% of total
eligible subjects were included in this genetic
analysis. Low participant rate of genetic analysis
may affect the statistical power to prove associa-
tions. Furthermore, only 49.5% of this subsample
had fundus photographs with sufficient quality for
computer-assisted measurement of retinal vessels.
Thus, unknown selection biases could have altered
these results. Second, we did not have a detailed
history of medications, including use of anti-
hypertensive agents. Current use of ACE inhibitors
to lower blood pressure could have influenced our
findings of an association between the ACE I/D
polymorphism and retinal vessel caliber. Also, we
were not able to measure plasma ACE levels in this
study.
In conclusion, we found that subjects with D/D of
the ACE I/D polymorphism had significant retinal
arteriolar narrowing, a subclinical structural marker
of chronic hypertension in this adult Japanese
population. This association was stronger in sub-
jects with a known history of hypertension. Our
finding suggests that the ACE I/D polymorphism
may influence the microvasculature, thereby
possibly contributing to genetic susceptibility for
the development of hypertension. Definitely, further
research is needed to confirm this finding in other
population-based samples.
Table 3 Difference in central retinal artery and vein equivalent (mm), by angiotensin converting enzyme insertion/deletion
polymorphisms, the Funagata study, Japan, 2000–02
N Mean vessel
diameter (s.d.) (mm)
Crude difference
(95% CI) (mm)
a
Age–gender-adjusted
(95% CI) (mm)
Multivariate adjusted
b
(95% CI) (mm)
Central retinal artery equivalent
(A) I/I polymorphism 164 179.50 (20.39) (reference) (reference) (reference)
I/D 170 179.46 (20.54)  0.33 ( 3.92, 3.26)  0.43 ( 3.98, 3.13)  0.32 ( 4.15, 3.51)
D/D 34 173.77 (19.73)  6.69 ( 12.88,  0.51)*  6.60 ( 12.78,  0.42)*  6.86 ( 13.58,  0.13)*
(D) I/I polymorphism 164 179.50 (20.39) (reference) (reference) (reference)
I/D or D/D 204 178.51 (20.47)  1.39 ( 4.84, 2.06)  1.50 ( 4.90, 1.91)  1.51 ( 5.21, 2.19)
(R) I/I or I/D polymorphisms 334 179.48 (20.44) (reference) (reference) (reference)
D/D 34 173.77 (19.73)  6.56 ( 12.45,  0.67)*  6.61 ( 12.43,  0.79)*  6.49 ( 12.86,  0.11)*
Central retinal vein equivalent
(A) I/I polymorphism 164 215.61 (21.52) (reference) (reference) (reference)
I/D 170 216.12 (20.37) 0.54 ( 3.14, 4.21) 0.60 ( 3.05, 4.26)  0.07 ( 3.87, 3.73)
D/D 34 217.37 (20.07) 5.22 ( 1.31, 11.74) 4.75 ( 1.78, 11.28) 3.93 ( 3.01, 10.88)
(D) I/I polymorphism 164 215.61 (21.52) (reference) (reference) (reference)
I/D or D/D 204 216.33 (20.28) 1.30 ( 2.22, 4.82) 1.31 ( 2.19, 4.81) 0.69 ( 2.78, 4.35)
(R) I/I or I/D polymorphisms 334 215.87 (20.92) (reference) (reference) (reference)
D/D 34 217.37 (20.07) 4.88 ( 1.16, 10.92) 4.55 ( 1.48, 10.58) 3.84 ( 2.51, 10.20)
Abbreviations: D, deletion polymorphism; I, insertion polymorphism.
Estimated b coefficient, using multiple linear regression models, represents a mean difference in retinal arteriolar diameter and venular diameter
by each unit change in genotype or allele, in additive (A), dominant (D) and recessive (R) models.
aAdjusted for central retinal vein equivalent in models of central retinal artery equivalent, and for central retinal artery equivalent in models of
central retinal vein equivalent, respectively.
bAdjusted for age, gender, systolic blood pressure, body mass index and smoking status.
*Po0.05.
What is known about this topic
K Retinal arteriolar narrowing is a structural sign associated
with chronic hypertension.
1
K A substantial proportion of the variation in retinal arteriolar
diameter might be genetically determined, independent of
concomitant risk factors.
4
K ACE I/D polymorphism is associated with hypertension
5
and atherosclerosis, such as carotid wall thickness
6 and
coronary heart disease.
7
What this study adds
K Subjects with D/D of the ACE I/D polymorphism had
significantly narrower retinal arteriolar caliber in this adult
Japanese population.
K ACE I/D polymorphism may influence the peripheral
microcirculation, thereby possibly contributing to genetic
susceptibility for the development of hypertension.
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